intranasal glutathione in parkinson's disease Treatment Revamping Parkinson's disease therapy using
Description
This project was realized with financial support of the project New Technologies for Translational Research in Pharmaceutical Sciences [NETPHARM, project ID CZ.02.01.01/00/22_008/0004607]co-funded by the European Union
Slowly, you might also observe the skin losing its radiance, antioxidant strength or ability to maintain pigmentation over time, particularly when excessive exposure to the sun, stress or pollution is present
According with this, we did not observe any accumulation of MDA neither in cells treated with TMZ or with QN, alone or in combination (Fig
BPC-157 ,
PMID: 12833459
Int J Mol Sci 17(5)
